Ambroxol as a Treatment for Parkinson's Disease Dementia

Clinical trial NCT02914366 · UNKNOWN

Trial details

NCT number: NCT02914366
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease Dementia

Start date: 2015-11-01
Primary completion: 2025-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.